Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03697733
Other study ID # Etovsfen
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date April 1, 2019

Study information

Verified date October 2018
Source Rajavithi Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison of the efficiency of oral Etoricoxib versus intravenous Fentanyl on post operative Pain in curettage under TIVA: A randomized controlled trial


Description:

Fractional Curettage is the most widely used for diagnostic and treatment abnormal uterine bleeding. The patient categorize post-operative pain as mild to moderate. Therefore, the effective analgesic added on intraoperative and post-operative is the most important factor in patient's satisfaction, patient well co-operation, shortness time of operation, decrease unpleasant symptoms and rapid recovery. However, there are many anesthetic technique that can be used to relive pain in the operation such as local anesthesia, total intravenous anesthesia, regional anesthesia or oral analgesic drugs.

Intravenous Fentanyl is an short acting opioid. It has a fast onset of action within 2 minutes and short duration of action 30-60 minutes. Respiratory depression, hypotension and bradycardia are adverse effects that might delayed discharge especially in one day surgery e.g. fractional curettage. Etoricoxib is an oral COX-2 specific inhibitor which can be used to relieve the pain. The onset of analgesia can be occurred within 24 minutes which peak plasma level within 60 minutes. There are many empirical evidences to support the results of post-operative pain after used oral Etoricoxib or intravenous Fentanyl. However, there are less evidences to support efficiency of oral Etoricoxib versus intravenous Fentanyl on post-operative Pain in fractional curettage under TIVA


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 1, 2019
Est. primary completion date April 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Women who having abnormal uterine bleeding undergoing fractional curettage under TIVA

Exclusion Criteria:

- Women who have opioid or NSAIDs allergy

- Women who disagree to participate in this study

- Women who have history of gastrointestinal bleeding or ulcer

- Women who have abnormal kidney function

- Women who can't understand Thai language

- Women who have American Society of Anesthesiologists [ASA] above 2

- Women who have been used NSAIDs in 48 hours or often used NSAIDs

Study Design


Intervention

Procedure:
fractional curettage
Fractional curettage under TIVA by used oral Etoricoxib120 mg at 30 minutes before fractional curettage and then added intravenous Propofol 2 mg/kg when start the procedure or Intravenous Fentanyl 1 microgram/kg and Propofol 2 mg/kg when start the procedure

Locations

Country Name City State
Thailand Rajavithi Hospital Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Rajavithi Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary post operative pain Compare efficacy of oral Etoricoxib and intravenous Fentanyl for post fractional curettage pain by using a visual analog pain scale [Score 0-10] at 60 minute after operation
Primary post operative pain Compare efficacy of oral Etoricoxib and intravenous Fentanyl for post fractional curettage pain by using a visual analog pain scale [Score 0-10] at 30 minute after operation
Primary post operative pain Compare efficacy of oral Etoricoxib and intravenous Fentanyl for post fractional curettage pain by using a visual analog pain scale [Score 0-10] at 15 minute after operation
Secondary Adverse effect from the drugs during and post operation Record subject experience of the following symptoms : nausea and vomiting ,dizziness, drowsiness ,allergic reaction ,chest pain ,and gastrointestinal bleeding or gastrointestinal discomfort since subject receive drugs until 60 minutes after procedure
Secondary Amount of intravenous Propofol used in the procedure Record dose of intravenous Propofol that used in TIVA only intraoperative time
Secondary The first time pain reliever was used in post operation Record the first time patient asked for post operative pain reliver or visual analog pain score > 5 within 60 minutes after the procedure
See also
  Status Clinical Trial Phase
Recruiting NCT06067217 - Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users N/A
Completed NCT03638856 - Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy N/A
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT01908738 - Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy N/A
Not yet recruiting NCT06050161 - Evaluating Artisential Laparoscopic Instruments in Gynecologic Surgery N/A
Completed NCT04381416 - Study to Assess the Safety and Efficacy of the IUB SEADâ„¢ Device N/A
Recruiting NCT06193590 - Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures N/A
Completed NCT02192606 - Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? N/A
Completed NCT01721304 - Decisionmaking for Abnormal Uterine Bleeding (AUB) N/A
Completed NCT05406960 - Therapeutic Effect of Herbal Infusion on Menometrorrhagia N/A
Recruiting NCT06024109 - Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Recruiting NCT06369012 - Management of Abnormal Uterine Bleeding N/A
Completed NCT06397898 - NOVasure EXpierences (NOVEX) N/A
Recruiting NCT05922657 - A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Recruiting NCT04311073 - Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies Phase 3
Not yet recruiting NCT06398145 - D-chiro-inositol and AUB Phase 2
Terminated NCT04475497 - Role of Blood Management in Perioperative Outcomes N/A
Recruiting NCT05062551 - Effectiveness of Three Steps Hysteroscopic Repair of Post Caesarean Isthmocele in Patients With Post Menstrual Spotting N/A
Terminated NCT05227456 - Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study Phase 2
Active, not recruiting NCT05299801 - DAta MIning to Evaluate Novasure Treatment